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an adrenal cause is suspected although hormonal tests are recommended as
first line.
Methods: On 134 hypertensive patients uncontrolled by at least a combi-
nation therapy and with a suspicion of secondary hypertension due to adrenal
cause, an abdominal CT scan was performed in first intention. In all subjects,
an exploration of the renin-aldosteron axis in standardized conditions, a 24-
hour urinary cortisol and a WHO recommended biological analysis were also
performed afterwards.
Results: An abnormal morphology of adrenal was detected in 57.5% of
patients. Observed abnormalities were: bilateral hyperplasia (30.6%), unilat-
eral adenoma (15.7%), unilateral hyperplasia (6.7%) and bilateral adenoma
(4.5%). Abnormal adrenal hormonal tests were recorded in 16.4% of patients,
with a primary aldosteronism (A/R corrected> 23) found in 10.4% and
increased urinary cortisol in 6%. Treatment implementation was decided upon
morphologic and hormonal results. At 6 months of follow-up, a controlled
blood pressure was observed in 73.1% of subjects, spironolactone had been
prescribed in 41.8% of subjects and adrenal surgery performed in 3.7% of
patients. If hormonal tests had only been performed, a retrospective analysis
showed that treatment with spironolactone would have been prescribed only in
12.6% of subjects and an adrenal surgery been proposed only in 2.9% of
patients.
Conclusion: In our population of patients with a resistant hypertension and
adrenal disease suspicion, abdominal CT scan as a first line investigation leads
directly to the conclusion of an adrenal aetiology in 45.5% of patients. In con-
trast, a specific treatment would have been undertaken only in 15.5% of
patients if screened by hormonal examinations only. This study suggests that
in subjects with uncontrolled hypertension and suspected to have an adrenal
cause, abdominal CT scan is an efficient first line investigation.
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Purpose: The purpose of the study was to determine the prognostic signif-
icance of vascular markers in apparently healthy subjects.
Methods: Analyses were based on the Third South-Western French
MONICA Survey (1995-1996) carried out in participants aged 35-64. Vital
status, date and cause of death were obtained 14 years after inclusion. Subjects
with a personal history of Atherosclerotic Cardiovascular Disease or with a
personal history of Severe Chronic Disease were excluded. Pulse Wave
Velocity (PWV), Pulse Pressure (PP), presence of carotid or femoral athero-
sclerotic plaques, and carotid Intima-Media Thickness (IMT) were assessed.
Identification of the determinants of cardiovascular mortality was based on a
multivariable survival analysis.
Results: There were 1144 participants (587 (51%) men). Over the 14-year
study period, there were 63 deaths, 21% due to a cardiovascular cause (Isch-
emic Heart Disease, Atherosclerotic Cerebrovascular Disease or Atheroscle-
rosis). The median 10-year risk of coronary event according to the
Framingham Risk Score (FRS) was 6.4%. PWV, PP, and carotid or femoral
atherosclerotic plaques were all significant and independent determinants of
cardiovascular mortality, whereas carotid IMT was no longer associated with
cardiovascular mortality after adjustment for FRS. The addition of PWV, PP
or atherosclerotic plaques to FRS in a prediction model resulted in an
improvement of the discriminatory value of the model as shown by the C-sta-
tistic which was 0.76 [95% CI: 0.61-0.90] for FRS alone, 0.80 [95% CI: 0.64-
0.95] for FRS and PWV, 0.80 [95% CI: 0.65-0.95] for FRS and PP, and 0.77
[95% CI: 0.60-0.94] for FRS and plaques. Using PWV, PP and plaques in the
prediction model led to a Net Reclassification Improvement of 22, 19 and
25%, respectively.
Conclusion: Vascular markers are independent determinants of cardiovas-
cular mortality risk in apparently healthy subjects in primary cardiovascular
prevention and improve classification of subjects.
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Purpose: Our objective was to assess the long term prognosis value of
ABI in a contemporary large cohort of pts with known CAD.
Methods. Among 834 consecutive male pts hospitalized in 2001-2004 for
coronary artery disease, ABI was measured in 776 pts. ABI –0.9 was consid-
ered as abnormal. ABI –0.9 and > 0.6 was considered as low and ABI0.6 as
very low. The median follow-up was 7.17 years. Total mortality was predicted
with a Cox proportional hazard model.
Results: Mean age (SD) was 60.2 (8.1), 144 pts (18.4%) were diabetic,
155 pts (19.8%) were smokers, and median heart rate was 61 bpm [Interqua-
tile range (IQR)] [57-70]. Mean left ventricular ejection fraction was 0.53
(0.13). 88.5% were on antiplatelet therapy, 75.2% on beta-blocker, 66% on
statin therapy and 54.8% on ACE inhibitors or ARB.
The sample comprised 518 pts (67%) with normal ABI and 258 (33%)
with abnormal ABI (215 (83.3%) pts had a low and 43 (16.7%) a very low
ABI). The cumulative seven-year total mortality rate was 17.6%. In the
normal ABI group, mortality rate was 13.9%, whereas it was 21.4% in the low
and 44.2% in the very low ABI group (p<0.001).
After multivariate adjustment for age, diabetes, tobacco consumption (none;
40 pack-years; >40 pack-years), heart rate, duration of CAD, left ventricular
ejection fraction (>0.5; 0.5 and > 0.35; 0.35), history of chronic obstructive
pulmonary disease or stroke, statin therapy and coronary revascularization,
hazard ratio (HR) for all-cause death was 1.36 (95% CI [0.92; 2.03] p=0.12) for
low ABI and 2.48 (95% CI [1.41; 4.36] p=0.002) for very low ABI compared
to pts with normal ABI. Including ABI in the prediction model significantly
increased the C-statistic (from 0.80 to 0.82, p=0.03).
Conclusion: ABI is a strong and independent long term predictor factor of
all-cause death in CAD. To better identify pts at very high risk, systematic
ABI assessment should be promoted.
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Background: Angina with angiographically normal coronary arteries
(NCA) still has controversial pathophysiological mechanisms. Experimental
studies have shown that coronary blood flow varies with aortic (Ao) stiffness,
but clinical data are poor.
Objective: To assess Ao vascular function by different echocardiographic
techniques in patients (pts) with angina and NCA vs asymptomatic pts.
Methods: Study group consisted of 15 pts with angina and NCA (mean
age 60,9±5,3 yrs) and 15 age and gender- matched control subjects (normal
and hypertensives pts) .
Ascending Ao diameters – derived stiffness indices were: Ao strain, Ao
distensibility (Ao dis), Ao stiffness index (Ao SI). Ao function was evaluated
also by measuring tissue Doppler (TdI) systolic (SW), early and late dia-
stolic(EW, AW) velocities of the anterior Ao wall. Total afterload was defined
by the effective arterial elastance (Ea=0.9XSBP/SV, SV=stroke volume). Sys-
temic vascular resistance index (SVRI)= mean arterial pressure/cardiac index.
Total arterial compliance (Ca)=SV/pulse pressure.
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Results: Pts with angina and NCA had decreased Ao strain and Ao dis and
increased Ao stiffness compared with control subjects: Ao Strain 17,7±7,4%
vs 24,8±10,8% (p=0,05), Ao Dis 078 ±0,3 vs 1,2±0,6cm2/dyne (p<0,05), Ao
SI 3,4±1,8 vs 1,9 ±0,5 (p<0,05).
TdI Ao wall velocity were decreased in pts group: SW 6,7±1,6 vs 10±1,9
cm/s, (p<0,05, Anova), EW 5,6±2,1 vs 9,4±2,7 cm/s (p<0,05), AW 7,1±2,3 vs
7,7±2,9 cm/s (p=0,4).
Ea and SVRI were increased and Ca decreased in patients with angina: Ea
2,1±0,5 vs 1,6±0,2 mmHg/ml (p<0,05), SVRI 2,9±0,8 vs 1,9±0,2 dyne *s
*m2/cm-5 (p<0,05), Ca 1,2±0,4 vs 1,6±0,3 ml/mm Hg (p<0,05).
Conclusion: Vascular function proved to be altered in patients with angina
and normal coronary arteries versus control subjects. These findings suggest a
possible pathophysiological link between large arteries stiffening, increased
afterload and angina symptoms, in the absence of coronary stenoses.
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Objective: To evaluate the performance and acceptance of the Screening
CardioVascular Lab (SCVL®, GenNov) as a screening and follow-up tool for
peripheral arterial disease (PAD) in the general practitioner's (GP) office. This
electronic device combines the oscillometric determination of the ankle-bra-
chial index (ABI) and the Edinburgh questionnaire (EQ).
Method: In a cross sectional study, 102 Belgian GPs recruited 505 patients
of 50 years, hospitalized within the last year for any ischemic event. The
electronic case report form was included in the SCVL®. 
Results: The patients were 69±11 years old (m±SD); men were 63%. Their
other CVR factors were: hypertension in 75%; dyslipidemia in 74%; seden-
tarily in 53%; abdominal obesity in 52%; familial history of CVD in 38%;
smoking in 28%; diabetes in 22%. The arterial events, which induced the
recent hospitalizations, were: acute in 71% of cases, planned for revascular-
ization in 23%; coronary in 50%, cerebral in 29%, aortic/peripheral in 15%.
For at least their hospitalization, 95% of patients were treated with antithrom-
botics, including 88% with antiplatelets. At the GP visit, PAD was previously
diagnosed by Doppler ultrasonography or arteriography in 13% of them. The
SCVL® returned the ABIs in 3±1 minutes. The patient ABI was of 0.95±0.20.
The EQ was positive, meaning a symptomatic PAD, in 16% of patients; the
patient ABI, < 0.90 in 37%; their combination, abnormal in 44%. The test sen-
sitivity increased from 64% for the single determination of the patient ABI to
79% for its combination with the EQ, while the specificity decreased from 67
to 61%. The GPs considered the SCVL® as easy-to-use with a score of 76±24/
100 and those experienced with handheld Doppler preferred the SCVL® with
a score of 73±30/100.
Conclusion: By automating combination of the oscillometric ABI and of
the Edinburgh questionnaire, the SCVL® emerges as an efficient and easy-to-
use device for the screening and follow-up of PAD by the GPs.
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Objective: To improve arterial rigidity in coronary patients
Methods: 48 coronary patients: 57 yrs; 15% women were compared with
16 volunteers: 51 yrs. Patients were included in a 4-week ambulatory educa-
tional program consisted of 22 meetings of cardiac rehabilitation, a therapeutic
and dietetic education and drugs adaptation following european recommanda-
tions. Patients and volunteers were examined at the beginning (Day 0 and 1),
at the end of the program (M1) and at 6 months. Brachial (average of 3 mea-
surements by OMRON M4) and central BP, pulse wave velocity (Sphyg-
mocor), heart rate, cholesterol, weight, smoking addiction and drug intake
were analysed by the same nurse. BP and PWV measurements at D1 were
used as baseline values. Percentage of variation for PWV between D1 and M1
for the volunteers was 6%.
Results: At M6 vs D1, patients risk factors were improved: total choles-
terol <5 mmol/l: 89 vs 50%, BP-140/90 mmHg: 96 vs 81%, smoking addic-
tion: 12.5 vs 15%, obesity (BMI>30): 15 vs 19%, diabete: 6% and
recommended treatment: 58% with beta blockers:79%, Aspirin: 100%, Statin:
96%, ACEI or sartan: 75%
Table – Results
Heart rate did not change significantly. The most important parameter to
explain the decrease of patients PWV was central BP after multiple regression.
Treatment did not significantly modify PWV, nor smoking addiction or total
cholesterol control (Student t test).
Conclusion: The education in a health network improved CV risk factors
and recommended treatment but also arterial rigidity in a few weeks. This
improvement was maintained although BP increased at M6 and heart rate did
not change during the study. This depends probably on an intrinsic improve-
ment of arterial rigidity of these coronary patients
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Objectives: the aims of our study were to assess the prevalence of signif-
icant lower limb arterial stenosis in a population of patients with an increased
cardiovascular risk and also to determine the best ankle brachial index
threshold value for its detection.
Methods: In patients with treated hypertension and/or another cardiovas-
cular risk factor (dyslipidemia, current smoking, diabetes), ankle brachial
index was measured using an automated oscillometric device with 2 synchro-
nized cuffs. The presence of atherosclerotic plaques was assessed indepen-
dently by a Doppler/ultrasound exam.
Results: We included 201 patients. Fifty two percent were men, of 58
±13,4 years old. Fifty 6 percent were treated for hypertension, 72% had dys-
lipidemia and 23% were treated for diabetes. There was 21% of current
smokers and 33% of previous smokers. A clinical peripheral arterial disease
was noted in 7% of the patients and the presence of a femoral stenosis >50%
in 7.7%. The prevalence of an ankle brachial index <0,9 was 19,7% and
16.6% for an ankle brachial index <0,85. The ankle brachial index perfor-
mance to detect a significant femoral plaque or a clinical peripheral arterial
disease is detailed in the table. The best predictors of the presence a peripheral
arterial disease or a significant plaque are one of the 3 following ankle bra-
chial index values: <0,85 or >1,30 or missing signal.
Conclusion: In patients with increased cardiovascular risk, the prevalence
of a significant inferior limb stenosis is 7.7%. The ankle brachial index is
easily and quickly measured by the automated SCVL® device. Our study
attests the feasibility of this approach to detect peripheral arterial disease and
arterial stenosis in daily practice in this population. 
Patients results: (mean) D1 M1 M6
Brachial BP (mmHg) 119/68 114/66* vs D1 122/69* vs M1
Central BP (mmHg) 110/69 106/66*vs D1 112/69*vs M1
PWV (m/s) 9.76 9.40*vs D1 9.42vs D1 (p: 0.057)
Volunteers results: (mean) D1 M1
Brachial BP (mmHg) 116/70 115/69
PWV (m/s) 8.6 8.8
